The UCSF-based Blood Systems Research Institute will conduct research using RainDance's digital PCR platforms as part of a new $20 million amfAR Institute for HIV Cure Research.
In PNAS this week: common variants that influence viral load in HIV patients, tumor evolution patterns, and more.
The scientists were able to edit CCR5, the receptor used by HIV to enter cells, without killing the stem cells.
Through a genome-wide association study, an international team of researchers has linked polymorphisms of large effect to host contribution to HIV viral load variation.
The method simplifies previous techniques, and preliminary testing using a microfluidic device indicates it could ultimately be used in low-resource settings.
The scientists fused Cas9 to zinc finger proteins to reduce off-target activity, essentially replacing the other nucleases that had been used with zinc fingers.
Following a beta evaluation of the system, a virology lab in Sheffield, UK, ran a workflow assessment and found improvements with the system.
In PLOS this week: parasitoid wasp sequences in butterflies and moths, nuclear sub-proteome of T. cruzi, and more.
The DxN Veris was recently launched as a CE-marked product with a menu of viral load tests, and will launch in a few years in the US with STD and HAI assays.
Roche's program will now include early infant HIV diagnostics for low- and middle-income countries.
CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.
Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.
Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.
In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.